	Programmed cell death ligand 1(PD-L1) association in metastatic and non-metastatic oral squamous cell carcinoma: clinicopathologic and immunohistochemical study. Sci Rep Kamel EM, Esmaeil DAM, Abdelsalam RA, El-Sisi AA. PMID: 42401619 [PubMed - indexed for MEDLINE]
	Re: Effect of anatomical site on prognosis and progression pattern in early-stage acral melanoma: A retrospective cohort study of 281 cases. J Am Acad Dermatol Tooba F, Khan AM, Talha M, Shah SA, Hasan AH. PMID: 42401257 [PubMed - as supplied by publisher]
	Outcomes reported in studies of anal high-grade squamous intraepithelial lesions treatments: systematic review. BJS Open Finch DA, Chaudhury MP, Morris R, Parkin E, Mitchell P, Martin-Hirsch P, Renehan AG, Fish R. PMID: 42400410 [PubMed - indexed for MEDLINE]
	Genome-Wide Association Study of Nevus Count Reveals Opposing Effects of Genetic Loci Near IRF4 and MC1R on Flat Versus Raised Nevus Count in the Brisbane Twin Nevus Study: A Cross-Sectional Analysis. Pigment Cell Melanoma Res Ingold N, Zhu G, Duffy DL, Mothershaw A, Martin NG, MacGregor S, Law MH. PMID: 42400230 [PubMed - indexed for MEDLINE]
	A machine-learning-derived multi-cell death mode signature predicts melanoma prognosis and reveals an immune-cold tumor microenvironment. Discov Oncol Wu D, Zhou Y, Fang J, Xie J, Ren J. PMID: 42399595 [PubMed - as supplied by publisher]
	Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy. Am J Clin Dermatol Heidrich I, Urhahn S, Gebhardt C, Smit DJ, Pantel K. PMID: 42399583 [PubMed - as supplied by publisher]
	Planar neural organoids as an advanced in vitro model to study patient-derived melanoma metastasis. Sci Rep Majumder J, Torr EE, Favreau PF, Ramamurthy A, Müller U, Sabat G, Lebakken CS, Murphy WL. PMID: 42399448 [PubMed - as supplied by publisher]
	The Rise in Homemade Sunscreen Trends and Future Impacts on Skin Cancer Risk: Systematic Review. JMIR Dermatol Kaftan G, Panillo M, Maxon L, Esposito E. PMID: 42398033 [PubMed - indexed for MEDLINE]
	Outcomes of Epidermal Growth Factor Receptor Inhibitors in Locally Advanced and Metastatic Anal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Mannan MS, Musheer A, Basharat A, Sial F, Khan MW, Al-Sadi A, Amin MK, Shahzad M. PMID: 42397650 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients. Ann Surg Oncol Dougherty KE, Peery GB, Saravanan A, Pham VP, Herremans K, Moschos SJ, Collichio FA, Ollila DW. PMID: 42397639 [PubMed - as supplied by publisher]
	Proteolysisâ€‘targeting chimeras in oral squamous cell carcinoma: Current evidence, translational challenges and future directions (Review). Mol Med Rep Bai Y, Ma D, Yang X, Wang M. PMID: 42396663 [PubMed - indexed for MEDLINE]
	Case Report: Kidney preservation using immune checkpoint inhibitors in Muir-TorrÃ© syndrome-associated upper tract urothelial carcinoma, with literature review. Front Immunol Hanna M, Bar-Sela G. PMID: 42396450 [PubMed - indexed for MEDLINE]
	Choroidal melanoma and polydactylous onychopapilloma leading to diagnosis of BAP1 tumor predisposition syndrome. Ophthalmic Genet Miano DI, Ferguson E, Oswalt C, Materin MA. PMID: 42394126 [PubMed - as supplied by publisher]
	Experiences of patient-led melanoma surveillance and teledermatology in underserved groups in the Melanoma Self-Surveillance Trial: A qualitative sub-study. J Telemed Telecare Kharel P, Medcalf E, Ackermann D, Williams J, Hersch J, Wu Z, Janda M, Drabarek D, Fann A, Bell K. PMID: 42393858 [PubMed - as supplied by publisher]
	Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years. Nat Commun Garbe C, Keim U, Amaral T, Ascierto PA, Bauer J, Dummer R, Eggermont AMM, Eigentler TK, Flatz L, Forchhammer S, Forschner A, Gandini S, Gershenwald JE, Hauschild A, Hoeller C, Kirkwood JM, Lebbe C, Long GV, Lorigan P, Luke JJ, Meier F, Metzler G, Nathan P, Postow MA, Robert C, Röcken M, Schadendorf D, Weide B, Whiteman D, Leiter U, Martus P. PMID: 42393046 [PubMed - indexed for MEDLINE]
	MAPK-driven remodeling of mitochondrial dynamics in melanoma: implications for metabolic plasticity and response to targeted therapy. Biochem Pharmacol Prado-Souza LFL, Grabauskas LA, Chaguri R, Cardoso CD, Urushima FY, Mangini LGR, Ramos VS, Rodrigues T. PMID: 42392545 [PubMed - as supplied by publisher]
	Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management. Crit Rev Oncol Hematol Long X, Wu T, Hou Y, Wang W, Xie R. PMID: 42392242 [PubMed - as supplied by publisher]
	Desmoplastic melanoma arising in lentigo maligna: Implications for general practice. Aust J Gen Pract Gonzalez Matheus I, Robinson C, Muir J. PMID: 42392214 [PubMed - indexed for MEDLINE]
	Clinical outcomes of tebentafusp in metastatic uveal melanoma: a systematic review and single-arm meta-analysis. Front Med (Lausanne) Cai H, Huang Z, Wang BL, Wei M, Tian M, Zheng H. PMID: 42388498 [PubMed]
	Oxidative Stress and Nrf2 Signaling Role in Oral Squamous Cell Carcinoma: A Double-Edged Sword. Biol Cell Khan AU, Khan A, Shal B, Khan S, Sarwar S, Ullah J, Ullah A, Rengasamy KR. PMID: 42388017 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 143736

Page 1 of 7187



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy